NotCo's vegan chicken is now on the menu of two new Burger King sandwiches and nuggets across locations in Chile.
Burger King says the growing demand for vegan options has made the partnership with NotCo, which debuted its vegan chicken last year, an easy decision.
NotCo has previously worked with Burger King on menu items in Chile and Paraguay.
The chicken's launching comes at the same time as Burger King is temporarily eliminating meat from its entire menu at two of its outlets in Chile. It has already been done by the fast food company, most recently in Europe at two sites in Switzerland. That came after its flagship London branch made a vegan change.
Similar to Impossible Foods, Burger King's most notable North American partner, NotCo is gaining consumer brand recognition to boost demand for vegan menu items.
Since NotCo, a Chilean food-tech business known for its Giusseppe AI technology raised $235 million in a Series D fundraising round with contributions from Lewis Hamilton, Roger Federer, and Oscar-winning singer and director Questlove, it's been a busy year.
With the capital from the previous year, NotCo entered the unicorn realm and received a $1.5 billion valuation, a first for a Chilean company. Only a year earlier, the business had a $250 million valuation. Matias Muchnick founded NotCo in 2015 to advance plant-based diets both in its home market of Latin America and throughout the rest of the world.
This spring, NotCo increased its market share in the US by teaming up with Shake Shack to create a dairy-free milkshake. With its NotBurgers, it expanded its influence in Canada as well.
NotCo and Kraft Heinz have created a new joint venture to develop plant-based products.


SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Asian Currencies Strengthen as Indian Rupee and Australian Dollar Rally
Asian Markets Slide as Silver Volatility, Earnings Season, and Central Bank Meetings Rattle Investors
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
The Beauty Beneath the Expressway: A Journey from Self to Service
India Budget 2025 Highlights Manufacturing Push but Falls Short of Market Expectations
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Dollar Holds Firm as Strong U.S. Data, Fed Expectations and Global Central Bank Moves Shape Markets
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Starmer’s China Visit Highlights Western Balancing Act Amid U.S.-China Rivalry 



